Amlodipine with letrozole as maintenance post-chemotherapy: targeting calcium calcineurin calmodulin pathway and aromatase inhibitor in disseminated endometrioid adenocarcinoma of the endometrium—a case report

Mukul Arvind Gharote & Amogh Satchidanand Kale et al. · 2025-04-15

2Citations
World is now clinging to immune checkpoint inhibitor in almost every type of cancer. PD-1 and PD-L1 inhibitor are taking over the treatment algorithm. But cost is an issue; we have a perspective to target energy mechanism of cytotoxic T cells to modulate the representation of PD-1 receptor so as to increase immunogenicity of cytotoxic T cells. Cellular energy mechanism is largely dependent on calcium channels and pharmacological modulation of it may help in modulating response of cytotoxic T cell. We hereby present a case of endometroid adenocarcinoma of endometrium successfully treated with CCB and hormonal treatment after a short course of chemotherapy (paclitaxel 80 mg/m
TL;DR

A case of endometroid adenocarcinoma of endometrium successfully treated with CCB and hormonal treatment and hints at possible role of calcium channel blockers (CCB) and calcium modulation, which plays a pivotal role in the energy mechanism of cytotoxic T cells.

AI-generated by Semantic Scholar

Authors
Mukul Arvind Gharote, Amruta Ashok Deshpande, Amogh Satchidanand Kale